Mika Nakayama

A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase.

T. Nakajima, T. Okanoue, M. Minami, 2005, Journal of hepatology.

First phase viral kinetic parameters and prediction of response to interferon alpha-2b/ribavirin combination therapy in patients with chronic hepatitis C.

T. Nakajima, T. Okanoue, M. Minami, 2006, Hepatology Research.

Prediction of Breakthrough Hepatitis due to Lamivudine-Resistant Hepatitis B Virus by a Sensitive Semiquantitative Assay Using Peptide Nucleic Acids

T. Nakajima, T. Okanoue, M. Minami, 2006, Intervirology.

Association between decreased grip strength in preschool children and the COVID-19 pandemic: an observational study from 2015 to 2021

A. Yuki, Y. Tamase, Mika Nakayama, 2023, Journal of Physiological Anthropology.